NDC 49281-426 – Fluzone Trivalent Northern Hemisphere
Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mg; Influenza A Virus A/michigan/105/2025 San-049a (h3n2)… · Injection, Suspension · Intramuscular
Product NDC49281-426
Product details
- Brand name
- Fluzone Trivalent Northern Hemisphere
- Generic name
- INFLUENZA A VIRUS A/Switzerland/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA103914
- Marketed since
- July 2, 2024
- Marketing end
- June 30, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49281-426-50 | 10 SYRINGE, GLASS in 1 PACKAGE (49281-426-50) / .5 mg in 1 SYRINGE, GLASS (49281-426-88) | Jul 2, 2024 |